NFKB1 and cancer: Given the importance of p105 as a suppressor of inflammation [12,21], this report also offers molecular insight that could potentially be exploited to therapeutically treat inflammatory disorders, autoimmunity, and cancers that are associated with uncontrolled NF-κB activation [13].